Hypertonicity regulates the aquaporin-2 promoter independently of arginine vasopressin

Nephrol Dial Transplant. 2005 Mar;20(3):509-15. doi: 10.1093/ndt/gfh677. Epub 2005 Jan 25.

Abstract

Background: Aquaporin-2 (AQP-2) is an arginine vasopressin (AVP)-regulated water channel in kidney collecting duct cells. The present study was undertaken to determine whether a change in tonicity could directly regulate the AQP-2 gene in an in vitro experiment.

Methods: Various fragments of the 5'-flanking region of the murine AQP-2 gene up to -9.5 kb were cloned into a luciferase (Luc) reporter plasmid, and they were transiently transfected into Madin-Darby canine kidney cells.

Results: Hypertonicity significantly increased the Luc activity of the constructs containing >6.1 kb of the 5'-flanking region of the AQP-2 gene (-6.1AQP2). However, promoter regions <4.3 kb in length containing the tonicity-responsive enhancer (TonE) at bp -570 to -560 were not stimulated by hypertonicity. The TonE-deleted construct which contains -9.5 to -1.1 kb of the 5' side of the AQP-2 gene, 8.4AQP2, was also stimulated by hypertonicity. Mitogen-activated protein (MAP) kinase inhibitors SB203580 and U0126 did not affect the Luc activity of -6.1AQP2 induced by hypertonicity. In addition, the vector expressing dominant-negative TonE-binding protein (TonEBP) did not affect the hypertonicity-induced Luc activity of -6.1AQP2. The Luc activity of -6.1AQP2 was stimulated by the overexpression of TonEBP. Hypertonicity further increased the Luc activity of -6.1AQP2 under the overexpression of TonEBP.

Conclusion: These findings indicate that hypertonicity regulates AQP-2 promoter activity via an AVP-independent mechanism, and that the tonicity-responsive element resides between the -6.1 and -4.3 kb 5'-flanking region of the AQP-2 gene, in which the structure and mechanism of response to hypertonicity could be distinct from those of TonE.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 5' Flanking Region / drug effects
  • Animals
  • Aquaporin 2
  • Aquaporins / drug effects*
  • Aquaporins / genetics*
  • Aquaporins / metabolism
  • Arginine Vasopressin / pharmacology
  • Cell Culture Techniques
  • Cyclic CMP / analogs & derivatives*
  • Cyclic CMP / physiology
  • Dogs
  • Genes, Reporter
  • Genetic Vectors
  • Kidney / cytology*
  • Kidney / drug effects*
  • Kidney / metabolism
  • Luciferases / metabolism
  • Mice
  • Plasmids
  • Promoter Regions, Genetic / drug effects*
  • Renal Agents / pharmacology
  • Saline Solution, Hypertonic / pharmacology*
  • Transfection

Substances

  • Aqp2 protein, mouse
  • Aquaporin 2
  • Aquaporins
  • Renal Agents
  • Saline Solution, Hypertonic
  • Arginine Vasopressin
  • Cyclic CMP
  • dibutyryl cyclic-3',5'-cytidine monophosphate
  • Luciferases